Nuvera Ready to Launch Tests for Endocrine Therapy, Chemotherapy Response in Breast Cancer

The company anticipates launching its two tests in a CLIA format at the end of the summer and submitting FDA approval for them next year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.